All Articles

A West Virginia jury awarded millions to Pardee's subsidiary after a utility's power lines blocked access to coal, but a lengthy legal appeal looms.

The self-storage giant affirmed its Q1 dividend, signaling stability to investors, but faces a mixed Wall Street outlook and a new legal challenge.

The pioneers behind modern Wi-Fi and super-dense computer chips, Andrea Goldsmith and Fabian Pease, will be inducted into the SVEC Hall of Fame.

Panama finalizes its multi-billion dollar bond tender offer, a strategic move to refinance debt amid fiscal pressures and a changing economic landscape.

The veteran-founded coffee brand is on the clock after its stock price fell below $1.00, triggering a six-month window to brew a market turnaround.

The junior miner's new Shareholder Rights Plan is a defensive maneuver. Is it a sign of confidence, a hint of vulnerability, or a growing industry trend?

With top proxy firms ISS and Glass Lewis on board, Criteo's plan to redomicile and simplify its stock structure is a major play for U.S. investors.

With a new interim CEO and mounting financial pressure, VERSES AI's upcoming investor webinar is a pivotal test of its bio-inspired AI vision.

After a 1,000% stock surge on promising clinical data, Nektar Therapeutics secures $460M, fueling its next chapter in immunotherapy amid high hopes and risks.

Safe Bulkers sells a 14-year-old ship for $35.2M, capitalizing on a strong market to fund a new generation of eco-friendly vessels.

Florida Poly's state-of-the-art esports arena isn't just for play. It's a strategic investment in tech careers, campus community, and the future of education.

The AI and GPU infrastructure firm has adopted a shareholder rights plan, a defensive move to thwart hostile takeovers and control its destiny.

Pharmaceutical giant Cencora locks in $3B in financing to pay down debt from its massive OneOncology acquisition, deepening its strategic bet on cancer care.

CenterWell's major acquisition of MaxHealth adds 82 clinics and 120,000 patients, deepening its hold on Florida's value-based senior care sector.

Enpro's 3.2% dividend hike reflects more than just stability; it's a sign of a successful growth strategy and robust health in key tech sectors.

Honeywell's $1.19 quarterly dividend highlights its robust financial health and commitment to shareholders, backed by a strong forecast for 2026.

As state and federal cuts threaten vital services, Bloomington Health Foundation offers critical bridge funding to stabilize local nonprofits on the brink.

A new $1,000 grant from entrepreneur Stuart Piltch isn't just about money; it's about instilling a customer-first mindset in the next generation of leaders.

Influential proxy advisors ISS and Glass Lewis urge shareholders to approve the C$36.60 per share cash offer, framing it as a secure exit for investors.

Disc Medicine's promising EPP drug hits a major roadblock as the FDA seeks more data, delaying hope for patients and setting up a high-stakes trial.